Depression Research and Treatment / 2011 / Article / Tab 3

Clinical Study

The Pharmacopsychometric Triangle to Illustrate the Effectiveness of T-PEMF Concomitant with Antidepressants in Treatment Resistant Patients: A Double-Blind, Randomised, Sham-Controlled Trial Revisited with Focus on the Patient-Reported Outcomes

Table 3

Comparison of clinician-rated and patient-rated HAM-D6. LOCF analysis.

HAM-D6ClinicianPatient
Active T-PEMFSham T-PEMFActive T-PEMFSham T-PEMF
( )( )( )( )

Baseline12.5 (2.1)12.5 (2.0)13.9 (2.2)13.8 (2.5)
week 110.6 (2.9)*11.7 (2.1)10.9 (3.8)11.2 (3.3)
week 29.7 (2.2)*10.6 (2.8)9.3 (3.0)*11.5 (4.4)
week 38.8 (2.3)*10.6 (3.1)8.6 (3.4)**11.9 (4.0)
week 47.9 (3.0)*10.8 (2.8)7.8 (3.3)**12.0 (4.0)
week 56.9 (3.7)*10.5 (3.2)7.0 (4.5)**10.8 (3.7)

* .
** .

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.